JNJ vs HUM
By Alex · Tickerpine
Johnson & Johnson vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | HUM |
|---|---|---|
| Price | $254.66 | $383.84 |
| Market cap | $613.02B | $46.08B |
| P/E ratio | 29.5 | 41.0 |
| ROE | 26.42% | 6.28% |
| Profit margin | 21.83% | 0.82% |
| Revenue growth | 9.90% | 23.50% |
| Dividend yield | 2.10% | 0.92% |
| Beta | 0.26 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs HUM in plain English
- JNJ is the bigger company — about 13.3× the market cap of HUM.
- JNJ is cheaper on earnings (P/E 29.5 vs 41.0).
- JNJ earns a higher return on equity (26% vs 6%).
- HUM is growing revenue faster (24% vs 10%).
- JNJ has the higher dividend yield (2.10% vs 0.92%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.